臺北醫學大學附設醫院

Medicine & Life Sciences

1. Anti-Inflammatory Agents 8%
2. Antioxidants 7%
3. Apoptosis 24%
4. Arsenic 9%
5. Autophagy 8%
6. Biomarkers 10%
7. Bipolar Disorder 13%
8. Blood Platelets 10%
9. Blood Pressure 8%
10. Bone and Bones 11%
11. Brain 7%
12. Breast Neoplasms 17%
13. Carcinoma 10%
14. Case-Control Studies 12%
15. Catenins 7%
16. Cell Line 8%
17. Cell Movement 9%
18. Cell Proliferation 8%
19. Child 8%
20. Chronic Renal Insufficiency 11%
21. Cohort Studies 29%
22. Colonic Neoplasms 9%
23. Colorectal Neoplasms 15%
24. Comorbidity 7%
25. Confidence Intervals 24%
26. Control Groups 8%
27. Cytokines 7%
28. Databases 14%
29. Datasets 7%
30. Down-Regulation 11%
31. Drug Therapy 8%
32. Endothelial Cells 8%
33. Endothelial Progenitor Cells 7%
34. Equipment and Supplies 7%
35. ErbB Receptors 7%
36. Fibrosis 8%
37. Gene Expression 10%
38. Genes 14%
39. Glioblastoma 7%
40. Glucose 7%
41. glucose-regulated proteins 7%
42. Growth 12%
43. Hepatocellular Carcinoma 17%
44. Hyperoxia 9%
45. Hypertension 8%
46. In Vitro Techniques 14%
47. Incidence 11%
48. Inflammation 14%
49. Kidney 12%
50. Lipopolysaccharides 10%
51. Liver 9%
52. Logistic Models 10%
53. Lung 14%
54. Lung Neoplasms 9%
55. Macrophages 9%
56. Magnetic Resonance Imaging 7%
57. Mesenchymal Stem Cells 9%
58. Messenger RNA 9%
59. Meta-Analysis 21%
60. MicroRNAs 8%
61. Mortality 16%
62. Mothers 7%
63. Mutation 7%
64. National Health Programs 13%
65. Neoplasm Metastasis 15%
66. Neoplasms 37%
67. Nitric Oxide 8%
68. Non-Small Cell Lung Carcinoma 7%
69. Obesity 7%
70. Odds Ratio 21%
71. Osteoarthritis 7%
72. Oxidative Stress 9%
73. Pain 7%
74. Parkinson Disease 7%
75. Pharmaceutical Preparations 8%
76. Phosphorylation 8%
77. Population 37%
78. Pregnancy 8%
79. Prostatic Neoplasms 9%
80. Proteins 16%
81. Radiotherapy 9%
82. Randomized Controlled Trials 13%
83. Reactive Oxygen Species 9%
84. Recurrence 8%
85. Renal Dialysis 10%
86. Retrospective Studies 12%
87. Robotics 8%
88. Sepsis 7%
89. Serum 15%
90. Sleep 7%
91. Stem Cells 10%
92. Stomach 7%
93. Stroke 25%
94. Survival 10%
95. Systematic Reviews 15%
96. Taiwan 100%
97. Therapeutics 26%
98. Traumatic Brain Injury 11%
99. Up-Regulation 9%
100. Wounds and Injuries 17%